← Open Payments lookup

MARK MITTAUER: Open Payments

NPI 1255322996 · GROTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,018 in 130 payments from 13 companies in 2025. Trend: 2023 $901 · 2024 $1,058 · 2025 $2,018

Food & beverage: $2,018
CompanyPaymentsAmount
ABBVIE INC.25$501
Neurocrine BioSciences, Inc.36$324
Otsuka America Pharmaceutical, Inc.16$301
Janssen Pharmaceuticals, Inc13$191
Alkermes, Inc.12$178
Teva Pharmaceuticals USA, Inc.8$154
Vanda Pharmaceuticals Inc.5$106
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$105
Axsome Therapeutics, Inc.3$46
Collegium Pharmaceutical, Inc.3$45

Products named: VRAYLAR, INGREZZA, REXULTI, ARISTADA, INVEGA SUSTENNA, FANAPT, CAPLYTA, SPRAVATO.

Industry payments across CT — which companies pay providers there.